Journal of Nuclear Medicine Technology June 2026, jnmt.126.272186; DOI: https://doi.org/10.2967/jnmt.126.272186 ...
Myocardial perfusion scintigraphy and 2-dimensional (2D) echocardiography are used for evaluating left ventricular function and ejection fraction (EF). This study aimed to validate the ...
Journal of Nuclear Medicine Technology June 2026, jnmt.126.272439; DOI: https://doi.org/10.2967/jnmt.126.272439 ...
Prostate cancer is a rapidly expanding area for radiopharmaceutical therapy, primarily driven by prostate-specific membrane antigen–targeted imaging and therapy. This growth necessitates new workflows ...
Journal of Nuclear Medicine Technology April 2026, jnmt.125.271114; DOI: https://doi.org/10.2967/jnmt.125.271114 ...
Journal of Nuclear Medicine Technology April 2026, jnmt.126.272015; DOI: https://doi.org/10.2967/jnmt.126.272015 ...
Journal of Nuclear Medicine Technology April 2026, jnmt.126.272024; DOI: https://doi.org/10.2967/jnmt.126.272024 ...
Journal of Nuclear Medicine Technology April 2026, jnmt.126.272482; DOI: https://doi.org/10.2967/jnmt.126.272482 ...
Journal of Nuclear Medicine Technology March 2026, jnmt.125.271050; DOI: https://doi.org/10.2967/jnmt.125.271050 ...
Journal of Nuclear Medicine Technology January 2026, jnmt.125.270526; DOI: https://doi.org/10.2967/jnmt.125.270526 ...
Journal of Nuclear Medicine Technology January 2026, jnmt.125.270563; DOI: https://doi.org/10.2967/jnmt.125.270563 ...
The widespread success of 177Lu-PSMA-617 for prostate cancer has generated unprecedented volume in theranostics. Prostate-specific membrane antigen–targeted theranostics is possibly the most complex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results